본문 바로가기 주메뉴 바로가기
22대 대한민국 국회 국회정보길라잡이 국회의원검색
회원가입 로그인
HOME

정보검색

소장정보 검색

국회도서관 홈으로 정보검색 소장정보 검색
결과 내 검색 동의어 포함
결과 내 검색 동의어 포함

-

목차보기

Title Page

Contents

Abstract (English) 8

Ⅰ. Introduction 10

Ⅱ. Material & Methods 13

1. Cells and reagents 13

2. Transfections 13

3. Quantitative Real-Time PCR (qRT-PCR) 14

4. Western Blotting (WB) 15

5. Luciferase Reporter Assays 16

6. Cell Viability 16

7. Drug Treatment Assays 17

8. Scratch Wound Healing Assays 17

9. Invasion Assays 18

10. Colony Formation Assays 18

11. In Vivo Studies 19

12. Statistics 20

Ⅲ. Results 21

1. DDX53 positively correlates with EC Metastasis 21

2. DDX53 increases the EC progression. 23

3. DDX53 Upregulates Chemoresistance and Mesenchymal Markers in EC Cells 25

4. Regulation of DDX53 expression by miR-429 through direct targeting of its 3'-UTR 27

5. MiR-429 regulates EC metastasis and proliferation by targeting DDX53 29

6. Downregulated miR-429 contributes to EMT and increased anti-cancer sensitivity in EC cells 32

7. The miR-429/DDX53 axis regulates in vivo EC tumor progression 34

Ⅳ. Discussion 36

Ⅴ. Conclusion 40

Ⅵ. Reference 41

Ⅶ. Abstract (Korean) 45

List of Figures

Figure 1. DDX53 regulation contributes to EC metastasis. 22

Figure 2. DDX53 increase the EC progression. 24

Figure 3. DDX53 Upregulates Chemoresistance and Mesenchymal Markers in EC Cells. 26

Figure 4. DDX53 is targeted by MiR-429. 28

Figure 5. MiR-429 regulates EMT in EC cells. 31

Figure 6. MiR-429 suppresses mesenchymal markers and chemoresistance. 33

Figure 7. In vivo miR-429/DDX53 axis therapeutic effects. 35

추천서가 (다양한 추천 자료를 만나보세요)

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차